ストックスクリーナーアプリを入手
1.40
4.48%
0.06
アフターアワーズ：
1.35
-0.05
-3.57%
前日終値:
$1.34
開ける：
$1.39
24時間の取引高:
18,072
Relative Volume:
0.06
時価総額：
$3.62M
収益：
$294.20K
当期純損益:
$-12.25M
株価収益率:
-0.2772
EPS:
-5.05
ネットキャッシュフロー:
$-10.77M
1週間 パフォーマンス:
+13.82%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+110.53%
1年 パフォーマンス:
+251.32%
1日の値動き範囲:
$1.38
$1.40
1週間の範囲:
$1.22
$1.40
52週間の値動き範囲:
$0.2375
$2.875
Aethlon Medical Inc Stock (AEMD) Company Profile
名前
Aethlon Medical Inc
セクター
電話
619-941-0360
住所
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
AEMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.40 | 2.69M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 再開されました | H.C. Wainwright | Neutral |
Aethlon Medical Inc (AEMD) 最新ニュース
What analysts say about Aethlon Medical Inc. stockAccelerated earnings growth - Autocar Professional
What drives Aethlon Medical Inc. stock priceHigh-velocity gains - jammulinksnews.com
Is Aethlon Medical Inc. a good long term investmentUnmatched market performance - jammulinksnews.com
Aethlon Medical Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Financial Comparison: Aethlon Medical (NASDAQ:AEMD) versus Centene (NYSE:CNC) - Defense World
What makes Aethlon Medical Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Why Aethlon Medical Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser
How Aethlon Medical Inc. stock performs during market volatilityFree Elite Traders Group - Newser
Aethlon Medical advances to next cohort in cancer device trial - Investing.com Australia
Aethlon Medical advances to next cohort in cancer device trial By Investing.com - Investing.com Canada
Breakthrough: Cancer Treatment Device Clears Critical Safety Hurdle, Next Trial Phase Begins - Stock Titan
Aethlon Medical Reports Progress in Cancer Trials - TipRanks
Aethlon Medical Drops 13.1% After Reverse Split - AInvest
Aethlon Medical (NASDAQ:AEMD) Rating Increased to Neutral at HC Wainwright - Defense World
HC Wainwright Upgrades Aethlon Medical (NASDAQ:AEMD) to Neutral - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by HC Wainwright - Defense World
AEMD: HC Wainwright & Co. Sets New Price Target for Aethlon Medi - GuruFocus
Zacks Small Cap Predicts Aethlon Medical Q1 Earnings - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2025 Earnings Call Transcript - Insider Monkey
Aethlon Medical | 4: Statement of changes in beneficial ownership of securities-Director BROENNIMAN EDWARD G - 富途牛牛
AEMD Stock Plummets Following Disappointing Earnings | AEMD Stoc - GuruFocus
AEMD: Aethlon Reports $5.5M Cash Balance as of March 31 | AEMD Stock News - GuruFocus
Aethlon Medical's Hemopurifier: A Pivotal EV-Targeted Breakthrough in a Multibillion-Dollar Market - AInvest
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025 - Finansavisen
AETHLON MEDICAL Earnings Preview: Recent $AEMD Insider Trading, Hedge Fund Activity, and More - Nasdaq
Medical Device Pioneer Aethlon Medical Sets Q4 Earnings Date, Cancer Treatment Updates Expected - Stock Titan
Aethlon Medical (AEMD) Expected to Announce Quarterly Earnings on Thursday - Defense World
AEMD Reaches Milestone in Australian Hemopurifier Trial | AEMD Stock News - GuruFocus
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial | AEMD Stock News - GuruFocus
Cancer Trial Breakthrough: Aethlon's Hemopurifier Shows Promise in Treating Therapy-Resistant Tumors - Stock Titan
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier By Investing.com - Investing.com South Africa
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier - Investing.com Nigeria
Aethlon Medical Inc (AEMD) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
大文字化:
|
ボリューム (24 時間):